Urokinase is an enzyme protein isolated from healthy human urine or
obtained from human kidney tissue culture. The urokinase can be extracted
through the urine extraction process, and the urokinase can be used for the
treatment of cardiovascular and cerebrovascular diseases and thrombus.
Significance of extracting urokinase production
At present, the commonly used thrombolytic drugs in China are alteplase and
urokinase. At present, the price of an alteplase on the market is about 5,000
yuan. For patients, the cost of one alteplase is about 8,000-9,000 yuan. ; while
urokinase is relatively cheap, one is about 300 yuan. The cost for one patient
is about 500 yuan, which is relatively cheap. There is currently no cheaper drug
on the market that can replace urokinase. Once a "life-saving drug" like
urokinase is out of stock on a large scale, the consequences will be disastrous.
During the epidemic, schools and factories were shut down, and many hospitals
were out of stock of urokinase, which has only been relieved now. Nine East
Technology calls on the whole society to support the collection of urokinase raw
materials. It is not difficult to solve this matter. For example, whether
relevant parties can renovate the existing public toilets, and directly consider
urine collection when building public toilets in the future. If this is done
well, it will bring hope to more patients.
The production and establishment of a crude urokinase plant are conducive
to alleviating the shortage of urokinase, which is the gospel for the majority
of patients with cardiovascular and cerebrovascular diseases. The renovation of
toilets without flushing and collecting urine can also save water and energy. In
addition to generating considerable economic benefits, it can also bring more
social benefits and environmental protection ecological benefits can be
considered as a venture capital project.